T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
RTX Corp
RTX
$302B
| $1.86B | 0.39% |
25,670,889
-25,319,182
| -50% | -$1.73B |
|
52
CVS Health
CVS
$120B
| $1.82B | 0.39% |
18,888,088
-2,133,178
| -10% | -$188M |
|
53
EQT Corp
EQT
$34B
| $1.81B | 0.39% |
44,005,091
+1,174,495
| +3% | +$55.5M |
|
|
54
Crown Castle
CCI
$31.3B
| $1.8B | 0.38% |
22,874,993
-11,306,862
| -33% | -$906M |
|
55
Home Depot
HD
$353B
| $1.74B | 0.37% |
16,599,137
-1,378,943
| -8% | -$134M |
|
56
Intercontinental Exchange
ICE
$84.9B
| $1.73B | 0.37% |
39,377,950
+1,911,180
| +5% | +$81.9M |
|
57
PepsiCo
PEP
$189B
| $1.72B | 0.36% |
18,171,478
-4,624,712
| -20% | -$443M |
|
58
Cisco
CSCO
$475B
| $1.71B | 0.36% |
61,417,324
+9,623,311
| +19% | +$248M |
|
59
Chevron
CVX
$386B
| $1.7B | 0.36% |
15,184,072
-1,189,303
| -7% | -$135M |
|
60
Netflix
NFLX
$311B
| $1.7B | 0.36% |
347,365,550
+40,179,720
| +13% | +$216M |
|
61
Eli Lilly
LLY
$1.08T
| $1.67B | 0.35% |
24,175,898
+7,351,235
| +44% | +$496M |
|
62
APA Corp
APA
$14.2B
| $1.65B | 0.35% |
26,370,087
+1,030,460
| +4% | +$73.3M |
|
63
Chipotle Mexican Grill
CMG
$40.5B
| $1.64B | 0.35% |
120,100,400
-48,089,200
| -29% | -$629M |
|
64
Regeneron Pharmaceuticals
REGN
$82.1B
| $1.62B | 0.34% |
3,939,854
+680,192
| +21% | +$267M |
|
65
O'Reilly Automotive
ORLY
$74.9B
| $1.6B | 0.34% |
124,887,855
-12,419,520
| -9% | -$146M |
|
|
LNKD
66
DELISTED
LinkedIn Corporation
LNKD
| $1.6B | 0.34% |
6,961,823
-28,272
| -0.4% | -$6.13M |
|
67
Range Resources
RRC
$9.5B
| $1.59B | 0.34% |
29,760,459
-1,757,497
| -6% | -$114M |
|
68
Vertex Pharmaceuticals
VRTX
$134B
| $1.58B | 0.34% |
13,290,603
-900,159
| -6% | -$101M |
|
69
Qualcomm
QCOM
$171B
| $1.54B | 0.33% |
20,771,114
-865,493
| -4% | -$63.3M |
|
70
Honeywell
HON
$72.9B
| $1.54B | 0.33% |
17,118,200
-76,349
| -0.4% | -$6.57M |
|
71
United Airlines
UAL
$41B
| $1.51B | 0.32% |
22,619,775
-3,278,816
| -13% | -$182M |
|
72
Citigroup
C
$228B
| $1.51B | 0.32% |
27,877,116
-286,385
| -1% | -$15.2M |
|
73
FirstEnergy
FE
$27.1B
| $1.5B | 0.32% |
38,377,466
-95,203
| -0.2% | -$3.49M |
|
74
FedEx
FDX
$76.3B
| $1.48B | 0.31% |
8,513,167
+971,326
| +13% | +$164M |
|
75
Incyte
INCY
$24.5B
| $1.47B | 0.31% |
20,152,359
-886,535
| -4% | -$57.9M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.